Mirae Asset Global Investments Co., Ltd.

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 1569395 SEOUL, M5

Position in ENTA

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$18,954

-$167 QoQ

Shares Held

1,300

-14.1% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 17 holders

Holding Since

Mar 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Mirae Asset Global Investments Co., Ltd. holds $279,047,947 across 206 Biotechnology names. ENTA ranks #168 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	210,209	$104,417,115
2	REGN	Regeneron Pharmaceuticals, Inc.	93,632	$58,383,296
3	ALNY	Alnylam Pharmaceuticals, Inc.	61,531	$18,522,675
4	MDGL	Madrigal Pharmaceuticals, Inc.	33,420	$17,944,868
5	ARGX	Argenx SE	11,164	$10,357,623
6	ONC	BeOne Medicines Ltd.	33,808	$9,634,265
7	RPRX	Royalty Pharma plc	150,556	$8,441,674
8	INCY	Incyte Corp	63,812	$7,233,728

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,954	1,300	-14.1%	Shares	Sole	2026-07-22
2026-03-31	$19,121	1,514	-57.8%	Shares	Sole	2026-05-04
2025-12-31	$56,519	3,584	+333.9%	Shares	Sole	2026-01-26
2025-09-30	$9,887	826	0.0%	Shares	Sole	2025-11-03
2025-06-30	$6,244	826	+15.7%	Shares	Sole	2025-07-21
2025-03-31	$3,941	714	+1.1%	Shares	Sole	2025-04-24
2024-12-31	$4,059	706	-94.5%	Shares	Sole	2025-01-27
2023-06-30	$275,011	12,851	+17.4%	Shares	Defined	2023-08-10
2023-03-31	$442,533	10,943	—	Shares	Defined	2023-05-04
No filing history on record for this holder in this stock.